Difficulty: Medium
Average Score: 71%
Practice
Which of the following antimalarial drugs causes a dose-dependent toxic state that includes flushed and sweaty skin, dizziness, nausea, diarrhea, tinnitus, blurred vision, and impaired hearing?
Correct answer
D
Rationale
In this context, the correct answer is D) Quinine. Quinine is known for causing a dose-dependent toxic state that presents with symptoms such as flushed and sweaty skin, dizziness, nausea, diarrhea, tinnitus, blurred vision, and impaired hearing. These side effects are characteristic of quinine toxicity and are important for healthcare providers to recognize when managing patients undergoing antimalarial therapy.
A) Amodiaquine is an antimalarial drug, but it is not associated with the specific toxic symptoms mentioned in the question stem. Amodiaquine is more commonly known for causing liver toxicity and agranulocytosis.
B) Primaquine is another antimalarial drug that is not linked to the toxic symptoms described in the question. Primaquine is known for its potential to cause hemolytic anemia in individuals with G6PD deficiency.
C) Pyrimethamine is primarily used in the treatment of toxoplasmosis and malaria. It is not associated with the toxic profile described in the question.
Educationally, understanding the side effect profiles of different medications is crucial for healthcare professionals to provide safe and effective care to their patients. In this case, recognizing the specific toxic symptoms of quinine can aid in early identification and management of quinine toxicity, improving patient outcomes.
A) Amodiaquine is an antimalarial drug, but it is not associated with the specific toxic symptoms mentioned in the question stem. Amodiaquine is more commonly known for causing liver toxicity and agranulocytosis.
B) Primaquine is another antimalarial drug that is not linked to the toxic symptoms described in the question. Primaquine is known for its potential to cause hemolytic anemia in individuals with G6PD deficiency.
C) Pyrimethamine is primarily used in the treatment of toxoplasmosis and malaria. It is not associated with the toxic profile described in the question.
Educationally, understanding the side effect profiles of different medications is crucial for healthcare professionals to provide safe and effective care to their patients. In this case, recognizing the specific toxic symptoms of quinine can aid in early identification and management of quinine toxicity, improving patient outcomes.